Oct 17 (Reuters) - ASIT BIOTECH SA ASIT.BR :
* ASIT BIOTECH MODE OF ACTION STUDY OF GP-ASIT+™ FOR GRASS
POLLEN
ALLERGY PUBLISHED IN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
(JACI)1
* DATA SHOW HOW GP-ASIT+™, ADMINISTERED IN A PRE-SEASONAL
3-WEEK
TREATMENT, IS ABLE TO RAPIDLY MODULATE CELLULAR RESPONSE AND
INDUCE PRODUCTION OF BLOCKING ANTIBODIES
* UNDERSTANDING UNDERPINNING MODE OF ACTION OF GP-ASIT+™
VALIDATES
ASIT+™PLATFORM AND ITS POTENTIAL TO GENERATE NEW PRODUCT
CANDIDATES AGAINST OTHER ALLERGIES
Source text for Eikon: ID:nBw48YgNta
Further company coverage: ASIT.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))